AR026605A1 - Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos - Google Patents
Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacosInfo
- Publication number
- AR026605A1 AR026605A1 ARP000106216A ARP000106216A AR026605A1 AR 026605 A1 AR026605 A1 AR 026605A1 AR P000106216 A ARP000106216 A AR P000106216A AR P000106216 A ARP000106216 A AR P000106216A AR 026605 A1 AR026605 A1 AR 026605A1
- Authority
- AR
- Argentina
- Prior art keywords
- neuromuscular
- mercapto
- derivative
- sureversion
- pharmacos
- Prior art date
Links
- 206010029315 Neuromuscular blockade Diseases 0.000 title abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- 230000002232 neuromuscular Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- -1 carboxyphenyl Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99309558 | 1999-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026605A1 true AR026605A1 (es) | 2003-02-19 |
Family
ID=8241767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106216A AR026605A1 (es) | 1999-11-29 | 2000-11-27 | Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos |
Country Status (33)
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6744471B1 (en) * | 1997-12-05 | 2004-06-01 | Olympus Optical Co., Ltd | Electronic camera that synthesizes two images taken under different exposures |
TWI242015B (en) | 1999-11-29 | 2005-10-21 | Akzo Nobel Nv | 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
AU2002220654A1 (en) * | 2000-11-02 | 2002-05-15 | Akzo Nobel N.V. | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders |
RU2006118802A (ru) | 2003-10-31 | 2007-12-10 | Дзе Юниверсити Оф Канзас (Us) | Сульфоалкилэфирные-алкилэфирные производные циклодекстрина |
JP2007538112A (ja) | 2004-01-29 | 2007-12-27 | ピナクル ファーマシューティカルズ | β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用 |
ES2717248T3 (es) | 2004-04-23 | 2019-06-20 | Cydex Pharmaceuticals Inc | Formulación de DPI que contiene sulfoalquil éter ciclodextrina |
RU2007133709A (ru) | 2005-01-28 | 2009-03-20 | Пиннекл Фармасьютиклз, Инк. (Us) | Производные в-циклодекстрина в качестве антибактериальных агентов |
PT2952197T (pt) | 2005-10-26 | 2017-07-28 | Cydex Pharmaceuticals Inc | Composições de éter sulfoalquílico de ciclodextrina e métodos para a sua preparação |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
US20090069412A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched sugammadex |
US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
US7938283B2 (en) * | 2008-06-20 | 2011-05-10 | Grainpro, Inc. | System and method for hermetic storage of agricultural commodities during shipping |
US10463677B2 (en) | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
CN101591402B (zh) * | 2009-05-05 | 2011-11-30 | 杭州奥默医药技术有限公司 | 6-脱氧砜类环糊精衍生物及其制备方法 |
US8492538B1 (en) | 2009-06-04 | 2013-07-23 | Jose R. Matos | Cyclodextrin derivative salts |
DE102010012281A1 (de) * | 2010-03-22 | 2011-09-22 | Fresenius Medical Care Deutschland Gmbh | Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin |
CN101864003B (zh) * | 2010-06-11 | 2012-05-02 | 漆又毛 | 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法 |
WO2012025937A1 (en) | 2010-08-25 | 2012-03-01 | Ramamohan Rao Davuluri | Improved process for preparation of sugammadex |
CN102060941B (zh) * | 2010-11-26 | 2012-12-26 | 漆又毛 | 6-脱氧α-氨基酸衍生物环糊精及制备和应用 |
HK1205157A1 (en) | 2012-02-15 | 2015-12-11 | Cydex Pharmaceuticals, Inc. | Manufacturing process for cyclodextrin derivatives |
CN110066351B (zh) | 2012-02-28 | 2022-06-14 | 锡德克斯药物公司 | 烷基化环糊精组合物及其制备和使用方法 |
JP5892847B2 (ja) * | 2012-04-27 | 2016-03-23 | Dowaホールディングス株式会社 | シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤 |
GB201211153D0 (en) * | 2012-06-22 | 2012-08-08 | Farmhispania | Pharmaceutical compositions |
MX360192B (es) | 2012-10-22 | 2018-10-24 | Cydex Pharmaceuticals Inc | Composiciones de ciclodextrinas alquiladas y procesos para preparar y usar las mismas. |
US9879096B2 (en) * | 2013-02-14 | 2018-01-30 | Neuland Laboratories Limited | Process for preparation of sugammadex sodium |
JP2017523260A (ja) | 2014-05-29 | 2017-08-17 | ユーティーアイ リミテッド パートナーシップ | シクロデキストリン系のポリアニオン性デンドリマーおよび非イオン性デンドリマー |
RU2705996C2 (ru) | 2014-06-26 | 2019-11-13 | Маруиси Фармасьютикал Ко., Лтд. | Препарат рокурония с улучшенной стабильностью |
CN105348412B (zh) * | 2014-08-22 | 2018-06-05 | 江苏恩华药业股份有限公司 | 一种舒更葡糖钠的纯化方法 |
FI3183295T3 (fi) | 2014-08-22 | 2023-09-25 | Cydex Pharmaceuticals Inc | Fraktioidut alkyloidut syklodekstriinikoostumukset ja menetelmät niiden valmistamiseksi ja käyttämiseksi |
EP3270941B1 (en) | 2015-03-19 | 2021-05-26 | Cydex Pharmaceuticals, Inc. | Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same |
CN104844732B (zh) * | 2015-03-27 | 2017-05-03 | 山东滨州智源生物科技有限公司 | 一种舒更葡糖钠的制备方法 |
US20180296679A1 (en) * | 2015-04-08 | 2018-10-18 | Chang-Chun Ling | Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof |
US10494450B2 (en) * | 2015-05-29 | 2019-12-03 | Lakshmi Prasad ALAPARTHI | Processes for preparation of Sugammadex and intermediates thereof |
CN104922693A (zh) * | 2015-06-19 | 2015-09-23 | 南开大学 | 一种阴离子型环糊精与抗癌药物包合物及制备方法 |
EP3359578A4 (en) * | 2015-10-07 | 2019-05-15 | UTI Limited Partnership | MULTIFUNCTIONAL POLYANIONIC CYCLODEXTRINDDRIMERE |
CN108291057B (zh) | 2015-11-25 | 2021-07-13 | 费森尤斯卡比依普莎姆有限责任公司 | 全氯代-γ-环糊精的晶体形式 |
EP3380530B1 (en) | 2015-11-25 | 2020-10-07 | Fresenius Kabi iPSUM S.r.l. | An improved process for the preparation of sugammadex and its intermediates |
EP3433285B1 (en) * | 2016-03-22 | 2020-06-03 | Fresenius Kabi iPSUM S.r.l. | An improved process for the preparation of sugammadex |
KR102277487B1 (ko) * | 2016-04-29 | 2021-07-15 | 알버론 파마 비.브이. | 응혈 촉진제로서 시클로덱스트린 |
ES2915423T3 (es) | 2016-06-23 | 2022-06-22 | Synthon Bv | Proceso de preparación de sugammadex |
US10526422B2 (en) | 2016-06-29 | 2020-01-07 | Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. | Process for preparation and purification of Sugammades sodium |
WO2017084401A1 (zh) | 2016-06-29 | 2017-05-26 | 北京睿创康泰医药研究院有限公司 | 舒更葡糖钠的制备及纯化方法 |
CN107778383B (zh) * | 2016-08-24 | 2020-03-10 | 王炳永 | 一种舒更葡糖钠的精制方法 |
US10385142B2 (en) | 2017-01-23 | 2019-08-20 | Scinopharm Taiwan, Ltd. | Method for preparing sugammadex sodium |
CA3062308A1 (en) | 2017-05-03 | 2018-11-08 | Cydex Pharmaceuticals, Inc. | Composition containing cyclodextrin and busulfan |
CN109021148B (zh) * | 2017-06-08 | 2020-11-10 | 天津科伦药物研究有限公司 | 一种制备舒更葡糖钠的方法 |
US10442871B2 (en) | 2017-06-22 | 2019-10-15 | Lawrence Livermore National Security, Llc | Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof |
EP3421504B1 (en) | 2017-06-30 | 2019-09-18 | Synthon B.V. | Process for making sugammadex |
US10233263B1 (en) * | 2017-08-23 | 2019-03-19 | Formosa Laboratories, Inc. | Method for preparation of sugammadex sodium |
TWI703163B (zh) * | 2017-08-23 | 2020-09-01 | 台耀化學股份有限公司 | 舒更葡糖鈉之製備方法及其晶型 |
EP3717521B1 (en) | 2017-11-27 | 2023-04-05 | Medichem, S.A. | Process for the synthesis of a cyclodextrin derivative |
CN107892727B (zh) * | 2017-11-27 | 2019-12-24 | 合肥博思科创医药科技有限公司 | 一种舒更葡糖钠的纯化方法 |
US11225565B2 (en) | 2018-04-06 | 2022-01-18 | Synthon B.V. | Purification of sugammadex |
KR102054228B1 (ko) * | 2018-05-28 | 2019-12-10 | 연성정밀화학(주) | 슈가마덱스 나트륨염의 제조방법 |
CN116375907A (zh) * | 2018-06-07 | 2023-07-04 | 默沙东有限责任公司 | 用于制备舒更葡糖的方法 |
CN110615860A (zh) * | 2018-06-20 | 2019-12-27 | 江苏恒瑞医药股份有限公司 | 一种舒更葡糖钠的纯化方法 |
ES3034771T3 (en) | 2018-08-02 | 2025-08-22 | Tapi Croatia Ind Ltd | Solid state forms of sugammadex sodium |
WO2020058987A1 (en) * | 2018-09-20 | 2020-03-26 | Natco Pharma Limited | An improved process for the preparation of sugammadex sodium and its novel polymorphic form |
JP2022501489A (ja) * | 2018-09-27 | 2022-01-06 | ヴェルテンシュタイン・バイオファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | スガマデクスの新規結晶型 |
JP6950966B2 (ja) * | 2018-11-01 | 2021-10-13 | 丸石製薬株式会社 | スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法 |
CN109438591B (zh) * | 2018-12-29 | 2021-02-09 | 博瑞生物医药(苏州)股份有限公司 | 舒更葡糖钠的制备工艺 |
CN109824800A (zh) * | 2018-12-29 | 2019-05-31 | 鼎元(天津)生物医药科技有限公司 | 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法 |
WO2020201930A1 (en) | 2019-03-29 | 2020-10-08 | Hospira, Inc. | An improved process for preparation of sugammadex acid and sugammadex sodium |
CN111978435B (zh) | 2019-05-22 | 2021-05-25 | 合肥博思科创医药科技有限公司 | 一种高纯度舒更葡糖钠的制备方法 |
US11324692B2 (en) | 2019-07-03 | 2022-05-10 | Galenicum Health S.L.U. | Method to prepare pharmaceutical compositions of suggamadex |
EP4023292A4 (en) * | 2019-08-30 | 2023-09-06 | TERUMO Kabushiki Kaisha | INJECTION FORMULATION |
RU2724900C1 (ru) * | 2019-10-24 | 2020-06-26 | Маруиси Фармасьютикал Ко., Лтд. | Препарат рокурония с улучшенной стабильностью |
CN111019016B (zh) * | 2019-12-27 | 2022-02-18 | 武汉嘉诺康医药技术有限公司 | 一种舒更葡糖钠杂质的合成方法 |
US20230167203A1 (en) | 2020-02-28 | 2023-06-01 | Medichem, S.A. | Method for drying sugammadex |
CN111714459B (zh) * | 2020-06-18 | 2022-06-14 | 广州瑞尔医药科技有限公司 | 一种注射用舒更葡糖钠粉针剂及其制备方法 |
US11097023B1 (en) | 2020-07-02 | 2021-08-24 | Par Pharmaceutical, Inc. | Pre-filled syringe containing sugammadex |
EP3932391A1 (en) | 2020-07-03 | 2022-01-05 | Galenicum Health S.L.U. | Method to prepare pharmaceutical compositions |
US11446325B2 (en) * | 2020-09-30 | 2022-09-20 | Cyclolab Cyclodextrin Research And Development Laboratory Ltd. | Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases |
US11945788B2 (en) | 2021-06-07 | 2024-04-02 | Nuray Chemicals Private Limited | Process for preparing pitolisant hydrochloride and solid-state forms thereof |
CN113637097A (zh) * | 2021-08-10 | 2021-11-12 | 北京恒创星远医药科技有限公司 | 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用 |
CN120392546A (zh) * | 2021-08-19 | 2025-08-01 | 北京费森尤斯卡比医药有限公司 | 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法 |
CN119679816A (zh) * | 2023-09-15 | 2025-03-25 | 杭州奥默医药股份有限公司 | 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3929813A (en) * | 1973-12-26 | 1975-12-30 | Interx Research Corp | Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same |
JPS52108027A (en) | 1976-03-09 | 1977-09-10 | Rikagaku Kenkyusho | Anticarcinogen |
US4816462A (en) | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
HU194858B (en) | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
IT1196033B (it) | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
GB8506792D0 (en) | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
GB8613688D0 (en) | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
JPH0819004B2 (ja) | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | 徐放性医薬製剤 |
HU201783B (en) | 1987-10-13 | 1990-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts |
US5017566A (en) | 1987-12-30 | 1991-05-21 | University Of Florida | Redox systems for brain-targeted drug delivery |
US5002935A (en) | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5173481A (en) | 1989-04-03 | 1992-12-22 | The United States Of America As Represented By The Department Of Health And Human Services | Preparation of specifically substituted cyclodextrins |
KR0163440B1 (ko) | 1989-04-03 | 1998-11-16 | 디르크 반테 | 사이클로덱스트린의 위치선택적 치환 방법 |
SU1703657A1 (ru) * | 1990-01-23 | 1992-01-07 | Пятигорский фармацевтический институт | Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие |
ATE113612T1 (de) * | 1990-03-15 | 1994-11-15 | Tanabe Seiyaku Co | Polysulfat eines cyclodextrinderivates und verfahren zu dessen herstellung. |
US5180716A (en) | 1990-08-01 | 1993-01-19 | The Regents Of The University Of California | Cyclodextrin complexes for neuraxial administration of drugs |
US5180176A (en) * | 1991-08-08 | 1993-01-19 | Far Great Plastics Industrial Co., Ltd. | Elastic truck for roller skates |
JP2556236B2 (ja) | 1991-08-29 | 1996-11-20 | 田辺製薬株式会社 | β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法 |
US5840881A (en) | 1992-11-27 | 1998-11-24 | Takeda Chemical Industries, Ltd. | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility |
US5767112A (en) | 1994-10-21 | 1998-06-16 | Poli Industria Chimica, S.P.A. | Muscle relaxant pharmaceutical compositions |
AU708107B2 (en) | 1994-11-04 | 1999-07-29 | Commonwealth Scientific And Industrial Research Organisation | Method for treating animals |
GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
US5935941A (en) | 1997-10-24 | 1999-08-10 | Pitha; Josef | Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity |
US5834446A (en) * | 1996-06-21 | 1998-11-10 | Queen's University At Kingston | Nerve process growth modulators |
JP4249282B2 (ja) | 1998-02-27 | 2009-04-02 | 日本食品化工株式会社 | 新規シクロデキストリン誘導体及びその製造方法 |
WO1999060987A2 (en) | 1998-05-29 | 1999-12-02 | Neurosciences Research Foundation, Inc. | Control of pain with endogenous cannabinoids |
WO2001012202A2 (en) | 1999-08-13 | 2001-02-22 | Akzo Nobel N.V. | Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
TWI242015B (en) | 1999-11-29 | 2005-10-21 | Akzo Nobel Nv | 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
US20020111377A1 (en) | 2000-12-22 | 2002-08-15 | Albany College Of Pharmacy | Transdermal delivery of cannabinoids |
ES2261646T3 (es) | 2001-02-14 | 2006-11-16 | Akzo Nobel N.V. | Derivados de ciclodextrina 2-alquilada: agentes de inversion del bloqueo neuromuscular inducido por farmacos. |
TW200402417A (en) | 2002-06-21 | 2004-02-16 | Akzo Nobel Nv | 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
-
2000
- 2000-11-08 TW TW089123585A patent/TWI242015B/zh not_active IP Right Cessation
- 2000-11-23 RU RU2002117302/04A patent/RU2260013C2/ru active Protection Beyond IP Right Term
- 2000-11-23 WO PCT/EP2000/011789 patent/WO2001040316A1/en active IP Right Grant
- 2000-11-23 AT AT00993261T patent/ATE288450T1/de active
- 2000-11-23 NZ NZ518752A patent/NZ518752A/xx not_active IP Right Cessation
- 2000-11-23 PL PL356097A patent/PL203012B1/pl unknown
- 2000-11-23 ES ES00993261T patent/ES2237496T3/es not_active Expired - Lifetime
- 2000-11-23 US US13/432,742 patent/USRE44733E1/en active Active
- 2000-11-23 MX MXPA02004940A patent/MXPA02004940A/es active IP Right Grant
- 2000-11-23 IL IL14942300A patent/IL149423A0/xx active Protection Beyond IP Right Term
- 2000-11-23 JP JP2001541070A patent/JP3880041B2/ja not_active Expired - Lifetime
- 2000-11-23 DK DK00993261T patent/DK1259550T3/da active
- 2000-11-23 DE DE60017947T patent/DE60017947T2/de not_active Expired - Lifetime
- 2000-11-23 CN CNB00816360XA patent/CN1188428C/zh not_active Expired - Lifetime
- 2000-11-23 CZ CZ20021814A patent/CZ298206B6/cs not_active IP Right Cessation
- 2000-11-23 AU AU54380/01A patent/AU776536B2/en not_active Expired
- 2000-11-23 CA CA002390463A patent/CA2390463C/en not_active Expired - Lifetime
- 2000-11-23 SK SK726-2002A patent/SK286282B6/sk not_active IP Right Cessation
- 2000-11-23 PT PT00993261T patent/PT1259550E/pt unknown
- 2000-11-23 HU HU0203755A patent/HU227451B1/hu active Protection Beyond IP Right Term
- 2000-11-23 EP EP00993261A patent/EP1259550B1/en not_active Expired - Lifetime
- 2000-11-23 BR BRPI0015947 patent/BRPI0015947B8/pt not_active IP Right Cessation
- 2000-11-23 DE DE122008000068C patent/DE122008000068I2/de active Active
- 2000-11-23 US US10/148,307 patent/US6670340B1/en not_active Ceased
- 2000-11-23 KR KR1020027006871A patent/KR100716524B1/ko not_active Expired - Lifetime
- 2000-11-27 AR ARP000106216A patent/AR026605A1/es active IP Right Grant
- 2000-11-28 PE PE2000001269A patent/PE20010902A1/es not_active IP Right Cessation
- 2000-11-28 CO CO00090982A patent/CO5251450A1/es active IP Right Grant
-
2002
- 2002-05-03 ZA ZA200203538A patent/ZA200203538B/en unknown
- 2002-05-28 NO NO20022522A patent/NO328790B1/no not_active IP Right Cessation
-
2003
- 2003-06-23 US US10/603,355 patent/US6949527B2/en not_active Expired - Lifetime
-
2006
- 2006-07-18 JP JP2006195089A patent/JP4563972B2/ja not_active Expired - Lifetime
-
2008
- 2008-08-06 NL NL300356C patent/NL300356I2/nl unknown
- 2008-11-25 CY CY200800018C patent/CY2008018I2/el unknown
- 2008-11-26 LU LU91501C patent/LU91501I2/xx unknown
- 2008-12-10 BE BE2008C047C patent/BE2008C047I2/fr unknown
- 2008-12-30 FR FR08C0052C patent/FR08C0052I2/fr active Active
-
2010
- 2010-11-10 NO NO2010019C patent/NO2010019I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026605A1 (es) | Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos | |
LU91160I2 (fr) | Ezetimible ou ses sels acceptés en combinaison avec Simvastatin (Inegy/Vytorin). | |
CY1105047T1 (el) | Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν | |
EA200400432A1 (ru) | Производные мочевины | |
AR048652A1 (es) | 4-fenilamino-quinazolin-6-il-amidas | |
CY1109153T1 (el) | Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης | |
ES2079534T3 (es) | Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados. | |
CY1106674T1 (el) | Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους | |
CY1110694T1 (el) | Μεθοδος παρασκευης παραγωγων της εχινοκανδινης | |
AR022423A1 (es) | Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento | |
NO990583D0 (no) | Cykliske eterforbindelser som natriumkanalmodulatorer | |
AR025103A1 (es) | Quelantes quimicos para la reversion del bloqueo neuromuscular inducido por farmacos | |
DE60316672D1 (de) | Polycyclische verbindungen als potenten alpha2-adrenoceptor antagonisten | |
DE69202286D1 (de) | Verfahren zur Färbung keratinischer Fasern mit Isatin oder Isatinderivaten zusammen mit Aminopyrimidin oder Aminopyridin und Färbemittel. | |
ES2187025T3 (es) | Nuevos agentes quelantes de hierro (iii) activos via oral. | |
AR030203A1 (es) | Derivados de carbamato de 2-(s)-hidroximutilina, composiciones farmaceuticas que los comprenden, procedimiento para prepararlos y 2(s), 11-dihidroxi protegida-mutilina como compuesto intermediario | |
ATE270691T1 (de) | Stabilisator zusammensetzung | |
IT1317048B1 (it) | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie | |
BR9812892A (pt) | 2 4-diamino-1,3,5-triazinas substituìdas e seu emprego como herbicidas | |
AR017851A1 (es) | Composicion farmaceutica que comprende un eter carboxialquilico y una estatina, primera composicion farmaceutica para el uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico y controlar el riesgo cardiaco adverso en un mamifero y conjunto para lograr dichos efectos terape | |
AR053987A1 (es) | Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas. | |
BR0308018A (pt) | Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo | |
PT1197485E (pt) | Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose | |
DK1257552T3 (da) | Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose | |
FI960487A0 (fi) | Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |